Avinash Kumar
Research Scientist
Cancer Research laboratories
Long Island University
United States of America
Biography
Dr. Kumar received his Ph.D. in protein biochemistry and biophysics in 2012, after which he was awarded the postdoctoral fellowship from Department of Biotechnology (DBT), Govt. of India to carry out his research on cancer biology and epigenetics. After completion of this fellowship Dr. Kumar worked as a postdoc research fellow at the Cancer Institute, UMMC from 2013-16. Only recently, he joined Long Island University, College of Pharmacy and Health Sciences as a Research Scientist for Cancer Research Laboratories and Director of the Small Animal Imaging core. For the past three years Dr. Kumar’s research has focused on understanding the role and regulation of metastasis-associated protein 1 (MTA1), a chromatin modifier, in prostate cancer biology and on utilization of dietary stilbenes, such as resveratrol and pterostilbene among others as MTA1 inhibitors for prostate cancer chemoprevention and treatment. Dr. Kumar is an ad-hoc as well as an active reviewer for some journals. He is the author of 11 peer-reviewed publications, two book chapters and 17 abstracts. Dr. Kumar is an associate member of the American Association for Cancer Research (AACR).
Research Interest
Protein biochemistry, biophysics,prostate cancer biology
Publications
-
Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. Annals of New York Academy of Sciences 1348:1-9, 2015
-
Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget 7:18469-18484, 2016
-
Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: In silico approach to understand biological actions. Molecular BioSystems 12, 1702, 2016